Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
NKGen Biotech (NKGN) has issued an update.
NKGen Biotech, Inc. has announced the appointment of Dr. Marco Gottardis as a Class I director, filling the vacancy left by Ms. Alana McNulty’s resignation. Dr. Gottardis, with a distinguished background in biopharmaceuticals, including leadership roles at Janssen Pharmaceuticals and consulting at Gottardis Biotech LLC, was also chosen to serve on the Audit, Compensation, and N&CG Committees. His appointment is accompanied by a compensation program and a stock option award, with no reported conflicts of interest or related party transactions.
Learn more about NKGN stock on TipRanks’ Stock Analysis page.
